[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Drugs for Vulvovaginal Candidiasis Sales Market Report Forecast 2017-2021

March 2017 | 130 pages | ID: G75C9DB8E0AEN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Bayer
Janssen
Viamet Pharmaceuticals
Actavis
Tianjin Kingyork Group
Tianjin Pacific Pharmaceutical
Cisen Pharmaceutical
company 8
company 9

Product Segment Analysis:
Miconazole
Clotrimazole
Fluconazole

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified analysis of major market segments
Global Drugs for Vulvovaginal Candidiasis Sales Market Report Forecast 2017-2021

1 DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET OVERVIEW

1.1 Product Overview and Scope of Drugs for Vulvovaginal Candidiasis
1.2 Classification of Drugs for Vulvovaginal Candidiasis
  1.2.1 Miconazole
  1.2.2 Clotrimazole
  1.2.3 Fluconazole
1.3 Application of Drugs for Vulvovaginal Candidiasis
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Drugs for Vulvovaginal Candidiasis Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Drugs for Vulvovaginal Candidiasis (2012-2021)
  1.5.1 Global Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2021)
  1.5.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON DRUGS FOR VULVOVAGINAL CANDIDIASIS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 DRUGS FOR VULVOVAGINAL CANDIDIASIS MANUFACTURING COST ANALYSIS

3.1 Drugs for Vulvovaginal Candidiasis Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL DRUGS FOR VULVOVAGINAL CANDIDIASIS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Drugs for Vulvovaginal Candidiasis Market Competition by Manufacturers
  5.1.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Share by Manufacturers (2012-2017)
5.2 Global Drugs for Vulvovaginal Candidiasis (Volume and Value) by Type
  5.5.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2012-2017)
  5.5.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2012-2017)
5.3 Global Drugs for Vulvovaginal Candidiasis (Volume and Value) by Regions
  5.3.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Regions (2012-2017)
5.4 Global Drugs for Vulvovaginal Candidiasis (Volume) by Application

6 UNITED STATES DRUGS FOR VULVOVAGINAL CANDIDIASIS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Drugs for Vulvovaginal Candidiasis Sales and Value (2012-2017)
  6.1.1 United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2017)
  6.1.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2017)
  6.1.3 United States Drugs for Vulvovaginal Candidiasis Sales Price Trend (2012-2017)
6.2 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturers
6.3 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type
6.4 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application

7 CHINA DRUGS FOR VULVOVAGINAL CANDIDIASIS (VOLUME, VALUE AND SALES PRICE)

7.1 China Drugs for Vulvovaginal Candidiasis Sales and Value (2012-2017)
  7.1.1 China Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2017)
  7.1.2 China Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2017)
  7.1.3 China Drugs for Vulvovaginal Candidiasis Sales Price Trend (2012-2017)
7.2 China Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturers
7.3 China Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type
7.4 China Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application

8 EUROPE DRUGS FOR VULVOVAGINAL CANDIDIASIS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Drugs for Vulvovaginal Candidiasis Sales and Value (2012-2017)
  8.1.1 Europe Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2017)
  8.1.2 Europe Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Drugs for Vulvovaginal Candidiasis Sales Price Trend (2012-2017)
8.2 Europe Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturers
8.3 Europe Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type
8.4 Europe Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application

9 JAPAN DRUGS FOR VULVOVAGINAL CANDIDIASIS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Drugs for Vulvovaginal Candidiasis Sales and Value (2012-2017)
  9.1.1 Japan Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2017)
  9.1.2 Japan Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Drugs for Vulvovaginal Candidiasis Sales Price Trend (2012-2017)
9.2 Japan Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturers
9.3 Japan Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type
9.4 Japan Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application

10 GLOBAL DRUGS FOR VULVOVAGINAL CANDIDIASIS MANUFACTURERS ANALYSIS

10.1 Bayer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Janssen
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Viamet Pharmaceuticals
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Actavis
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Tianjin Kingyork Group
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Tianjin Pacific Pharmaceutical
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Cisen Pharmaceutical
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 company
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 company
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET FORECAST (2017-2021)

13.1 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue Forecast (2017-2021)
13.2 Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Regions (2017-2021)
13.3 Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2017-2021)
13.4 Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2017-2021)

14 APPENDIX


LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Vulvovaginal Candidiasis
Table Classification of Drugs for Vulvovaginal Candidiasis
Figure Global Sales Market Share of Drugs for Vulvovaginal Candidiasis by Type in 2015
Table Applications of Drugs for Vulvovaginal Candidiasis
Figure Global Sales Market Share of Drugs for Vulvovaginal Candidiasis by Application in 2015
Figure United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2021)
Figure China Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2021)
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2021)
Figure Japan Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2021)
Figure Global Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2021)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2021)
Table Global Drugs for Vulvovaginal Candidiasis Sales of Key Manufacturers (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers (2012-2017)
Figure 2015 Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers
Figure 2016 Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers
Table Global Drugs for Vulvovaginal Candidiasis Revenue by Manufacturers (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers
Table 2016 Global Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers
Table Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share by Type (2012-2017)
Figure Sales Market Share of Drugs for Vulvovaginal Candidiasis by Type (2012-2017)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Type (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Vulvovaginal Candidiasis by Type (2012-2017)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Growth Rate by Type (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Regions (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share by Regions (2012-2017)
Figure Sales Market Share of Drugs for Vulvovaginal Candidiasis by Regions (2012-2017)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Regions (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Regions (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Drugs for Vulvovaginal Candidiasis by Regions (2012-2017)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Growth Rate by Regions (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2012-2017)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share by Application (2012-2017)
Figure Sales Market Share of Drugs for Vulvovaginal Candidiasis by Application (2012-2017)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Application (2012-2017)
Figure United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2017)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2017)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Price Trend (2012-2017)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Manufacturers (2012-2017)
Table United States Drugs for Vulvovaginal Candidiasis Market Share by Manufacturers (2012-2017)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Type (2012-2017)
Table United States Drugs for Vulvovaginal Candidiasis Market Share by Type (2012-2017)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Application (2012-2017)
Table United States Drugs for Vulvovaginal Candidiasis Market Share by Application (2012-2017)
Figure China Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2017)
Figure China Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2017)
Figure China Drugs for Vulvovaginal Candidiasis Sales Price Trend (2012-2017)
Table China Drugs for Vulvovaginal Candidiasis Sales by Manufacturers (2012-2017)
Table China Drugs for Vulvovaginal Candidiasis Market Share by Manufacturers (2012-2017)
Table China Drugs for Vulvovaginal Candidiasis Sales by Type (2012-2017)
Table China Drugs for Vulvovaginal Candidiasis Market Share by Type (2012-2017)
Table China Drugs for Vulvovaginal Candidiasis Sales by Application (2012-2017)
Table China Drugs for Vulvovaginal Candidiasis Market Share by Application (2012-2017)
Figure Europe Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2017)
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2017)
Figure Europe Drugs for Vulvovaginal Candidiasis Sales Price Trend (2012-2017)
Table Europe Drugs for Vulvovaginal Candidiasis Sales by Manufacturers (2012-2017)
Table Europe Drugs for Vulvovaginal Candidiasis Market Share by Manufacturers (2012-2017)
Table Europe Drugs for Vulvovaginal Candidiasis Sales by Type (2012-2017)
Table Europe Drugs for Vulvovaginal Candidiasis Market Share by Type (2012-2017)
Table Europe Drugs for Vulvovaginal Candidiasis Sales by Application (2012-2017)
Table Europe Drugs for Vulvovaginal Candidiasis Market Share by Application (2012-2017)
Figure Japan Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2012-2017)
Figure Japan Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2012-2017)
Figure Japan Drugs for Vulvovaginal Candidiasis Sales Price Trend (2012-2017)
Table Japan Drugs for Vulvovaginal Candidiasis Sales by Manufacturers (2012-2017)
Table Japan Drugs for Vulvovaginal Candidiasis Market Share by Manufacturers (2012-2017)
Table Japan Drugs for Vulvovaginal Candidiasis Sales by Type (2012-2017)
Table Japan Drugs for Vulvovaginal Candidiasis Market Share by Type (2012-2017)
Table Japan Drugs for Vulvovaginal Candidiasis Sales by Application (2012-2017)
Table Japan Drugs for Vulvovaginal Candidiasis Market Share by Application (2012-2017)
Table Bayer Basic Information List
Table Bayer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table Janssen Basic Information List
Table Janssen Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table Viamet Pharmaceuticals Basic Information List
Table Viamet Pharmaceuticals Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Viamet Pharmaceuticals Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table Actavis Basic Information List
Table Actavis Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actavis Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table Tianjin Kingyork Group Basic Information List
Table Tianjin Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Tianjin Kingyork Group Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table Tianjin Pacific Pharmaceutical Basic Information List
Table Tianjin Pacific Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Tianjin Pacific Pharmaceutical Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table Cisen Pharmaceutical Basic Information List
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table company 8 Basic Information List
Table company 8 Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 8 Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Drugs for Vulvovaginal Candidiasis Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Vulvovaginal Candidiasis
Figure Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
Figure Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2015
Table Major Buyers of Drugs for Vulvovaginal Candidiasis
Table Distributors/Traders List
Figure Global Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2017-2021)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate Forecast (2017-2021)
Table Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Regions (2017-2021)
Table Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2017-2021)
Table Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bayer, Janssen, Viamet Pharmaceuticals, Actavis, Tianjin Kingyork Group, Tianjin Pacific Pharmaceutical, Cisen Pharmaceutical

More Publications

Need Help?

Ask a Question

Market Reports

All Categories